The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

Eur Heart J. 2021 Feb 11;42(6):657-670. doi: 10.1093/eurheartj/ehaa1061.
No abstract available

Keywords: Activators of soluble guanylate cyclase; Angiotensin receptor–neprilysin inhibitors; Biomarkers; Cardiac myosin activators and inhibitors; Clinical practice; Epidemiology; Heart failure; Imaging; Pharmacotherapy; Randomized control trials; SGLT-2 inhibitor; Telemedicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Cardiomyopathies* / therapy
  • Drug Combinations
  • Heart Failure* / therapy
  • Humans
  • Neprilysin
  • Tetrazoles

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Drug Combinations
  • Tetrazoles
  • Neprilysin